Samsung Biologics launches all-cash bid for PolyPeptide
July 20, 2026 | 10:13
Samsung Biologics launched an all-cash public tender offer to acquire 100 per cent of PolyPeptide Group, accelerating its multi-modality strategy and expanding its global manufacturing network across the US, Europe and India.
Mobile Version